Author:
Bulik Cynthia M.,Micali Nadia,MacDermod Casey M.,Qi Baiyu,Munn-Chernoff Melissa A.,Thornton Laura M.,White Jennifer,Dinkler Lisa,Pisetsky Emily M.,Johnson Jessica,Devine Katelin R.,Ortiz Shelby N.,Silverman Ava E.,Berthold Natasha,Dumain Alexis,Guintivano Jerry,Halvorsen Matthew,Crowley James J.
Abstract
Abstract
Background
The Avoidant Restrictive Food Intake Disorder – Genes and Environment (ARFID-GEN) study is a study of genetic and environmental factors that contribute to risk for developing ARFID in children and adults.
Methods
A total of 3,000 children and adults with ARFID from the United States will be included. Parents/guardians and their children with ARFID (ages 7 to 17) and adults with ARFID (ages 18 +) will complete comprehensive online consent, parent verification of child assent (when applicable), and phenotyping. Enrolled participants with ARFID will submit a saliva sample for genotyping. A genome-wide association study of ARFID will be conducted.
Discussion
ARFID-GEN, a large-scale genetic study of ARFID, is designed to rapidly advance the study of the genetics of eating disorders. We will explicate the genetic architecture of ARFID relative to other eating disorders and to other psychiatric, neurodevelopmental, and metabolic disorders and traits. Our goal is for ARFID to deliver “actionable” findings that can be transformed into clinically meaningful insights.
Trial registration
ARFID-GEN is a registered clinical trial: clinicaltrials.gov NCT05605067.
Funder
National Institute of Mental Health
Karolinska Institute
Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献